Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes
Journal of Endocrinological Investigation · 2008-08 · 31 (8) · 694-699
DOI: 10.1007/bf03346417 ↗At a glance
Randomisierte kontrollierte Studie in Journal of Endocrinological Investigation, published online on 2014-03-27. Written by M Cruz and 6 co-authors. Institution: Biochemistry Medical Research Unit, Hospital de Especialidades, Centro Medico Nacional Siglo XXI. IMSS, Col. Doctores. México DF, Mexico City, México…. Cited 91 times so far (Crossref); 28 references.
Topics: Diabetes mellitus
Abstract (original language)
BACKGROUND: Amino acids have been shown to stimulate insulin secretion and decrease glycated hemoglobin (A1C) in patients with Type 2 diabetes. In vitro, glycine reduces tumor necrosis factor (TNF)-alpha secretion and increases interleukin-10 secretion in human monocytes stimulated with lipopolysaccharide. The aim of this study was to determine whether glycine modifies the proinflammatory profiles of patients with Type 2 diabetes. MATERIALS/SUBJECTS AND METHODS: Seventy-four patients, with Type 2 diabetes were enrolled in the study. The mean age was 58.5 yr, average age of diagnosis was 5 yr, the mean body mass index was 28.5 kg/m2, the mean fasting glucose level was 175.5 mg/dl and the mean A1C level was 8%. They were allocated to one of two treatments, 5 g/d glycine or 5 g/d placebo, po tid, for 3 months. RESULTS: A1C levels of patients given glycine were significantly lower after 3 months of treatment than those of the placebo group. A significant reduction in TNF-receptor I levels was observed in patients given glycine compared with placebo. There was a decrease of 38% in the interferon (IFN)-gamma level of the group treated with placebo, whereas that of the group treated with glycine increased up to 43%. These data showed that patients treated with glycine had a significant decrease in A1C and in proinflammatory cytokines and also an important increase of IFN-gamma. CONCLUSION: Treatment with glycine is likely to have a beneficial effect on innate and adaptive immune responses and may help prevent tissue damage caused by chronic inflammation in patients with Type 2 diabetes.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Biochemistry Medical Research Unit, Hospital de Especialidades, Centro Medico Nacional Siglo XXI. IMSS, Col. Doctores. México DF, Mexico City, México. mcruzl@yahoo.com
Cite
APA
Cruz, M., Maldonado-Bernal, C., Mondragón-Gonzalez, R., Sanchez-Barrera, R., Wacher, N. H., Carvajal-Sandoval, G., & Kumate, J. (2008). Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes. Journal of Endocrinological Investigation, 31(8), 694-699. https://doi.org/10.1007/bf03346417
Vancouver
Cruz M, Maldonado-Bernal C, Mondragón-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, et al. Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes. Journal of Endocrinological Investigation. 2008;31(8):694-699. doi:10.1007/bf03346417
BibTeX
@article{Cruz2008,
author = {Cruz, M and Maldonado-Bernal, C and Mondragón-Gonzalez, R and Sanchez-Barrera, R and Wacher, N H and Carvajal-Sandoval, G and Kumate, J},
title = {Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes},
journal = {Journal of Endocrinological Investigation},
year = {2008},
volume = {31},
number = {8},
pages = {694--699},
doi = {10.1007/bf03346417}
}
EUVIMED